For example, patients with Milroy’s disease, one of the most extensively studied hereditary congenital lymphedema disorders, have inactivating autosomal dominant mutations within the Fms-related tyrosine kinase 4 (FLT4) gene encoding VEGFR3 expression [47,48,49,50]. This evidence concerns the gene FLT4 and Milroy disease.